##plugins.themes.bootstrap3.article.main##

Sandra Milena Camelo Roa Alfredo Ardila

Resumen

El uso de este tóxico en Colombia con fines delincuenciales representa un problema social y de salud de proporciones inmensurables, de ahí la importancia de conocer sus efectos a corto y largo plazo en la memoria y las habilidades conceptuales. Se evaluaron los efectos de la intoxicación por escopolamina sobre memoria, categorización y clasificación en 20 sujetos, entre 15 y 60 años. Se utilizó un diseño prospectivo con dos mediciones. Los sujetos fueron evaluados a los cinco días después de egresar de la clínica y a los seis meses. Los no expuestos se evaluaron paralelamente en los dos momentos de la evaluación, por medio de la prueba de memoria de Wechsler, el test de la figura de Rey-Osterrieth, el test de clasificación de tarjetas de Wisconsin y la subprueba de matrices progresivas del WAIS III. Los resultados obtenidos sugieren que la intoxicación por escopolamina provoca deterioro en la memoria y las habilidades conceptuales tanto a corto como a largo plazo.

##plugins.themes.bootstrap3.article.details##

Palabras Clave

escopolamina, intoxicación, memoria, habilidades conceptuales

Referencias
Aggleton, J.P., Keith, A.B. & Sahgal, A. (1990).The effects of mammillary body and combined amygdala-fornix lesions on test of delayed non-matching to sample in the rat. Behavioral Brain Research, 40, 145-157.

Córdoba, D. & Guerrero, A. (2001). Toxicología. Bogotá: Manual Moderno.

Curran, H.V., Schifano, F. & Lader, M. (1991). Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Psychopharmacology, 103, 83-90.

Duarte, J. (1999). La droga hipnótica: Recuperado de http://www.unidoqui.co

Duka, T., Ott, H., Rohloff, A. & Voet, B. (1996). The effects of a benzodiazepine Receptor antagonist beta-carboline ZK-93426 on scopolamine induced impairment on attention, memory and psychomotor skills. Psychopharmachology, 123, 361-73.

Dunnett, S.B. (1985). Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology, 87, 357-363.

Ebert, U. & Kirinch, W. (1998). Scopolamine model of dementia: electroencephalogram findings and cognitive performance. European Journal of clinical Investigation, 28, 944-949.

Ebert, U., Siepmann, M., Oertel, R., Wesnes, K. & Kirch, W. (1998). Pharmocokinetics and Pharmacodynamics of scopolamine after subcutaneus administration. The American college of Clinical Pharmachology, Inc, 38, 720-726

Flicker, C, Serby, M. & Ferris, S.M. (1990). Scopolamine effects on memory, language, visiospatial praxis and psychomotor speed. Psychopharmachology, 100, 243-50.

Frithy, C.D., Richardson, J.T.E., Samuel, M., Crow, T.J. & McKenna, P.J. (1984). The effects of intravenous diazepan and hyoscine upon human memory. Quartely Journal of Experimental Psychology, 36A, 133-144.

Ghoneim, M.M. & Mewaldt, S.P. (1975). Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory. Psychopharmacologia, 44, 257-262.

Ghoneim, M.M. & Mewaldt, S.P. (1977). Studies on human memory: The interactions of diazepam, scopolamine and pshysostigmine. Psychopharmacología, 52, 1-6.

Harder, J.A., Baeker, H.F. & Ridley, R.M. (1998). The role of central cholinergic projections in cognition: implications of the effects of scopolamine on discrimination learning by monkeys. Brain Research Bulletin, 45, 319-26.

Harper, D.N. Dalrymple-Alford, J.C. & McLean, A.P. (1993). The effect of medial septal and mammillary body lesions on the serial position curve in rats. Psychobiology, 21, 130-138.

Harper, D.N., McLean, A.P. & Dalrymple-Alford, J.C. (1994). Forgetting in rats following medial septum or mammillary body damage. Behavioral Neuroscience, 108, 691-702.

Hasselmo, M.E. & Wyble, B.P. (1997). Free recall and recognition in a network model of the hippocampus simulating effects of scopolamine on human memory function. Behavioral Brain Reseach, 89, 1-34.

Heaton, Chelune, Talley, Kay & Curtiss, (2001). Test de Clasificación de Tarjetas de Wisconsin. Madrid: TEA Ediciones.

Howard, M.W. & Kahana, M.J. (1999). Contextual variability and serial position effects in free recall. Journal of Experimental Psychology: Learning, Memory and Cognition, 25, 923-941.

Howard, M.W. & Kahana, M.J. (2002). A distributed representation of temporal context. Journal of Mathematical Psychology, 46(3), 269-299.

Jones, D.M., Jones, M.E., Lewis, M.J. & Spriggs, T.L.B. (1979). Drugs and memory: Effects of low doses nitrazepam and hyoscine on retention. British Journal of Clinical Pharmacology, 7, 479-483.

Kirk, R.C., White, K.G. & McNaughton, N. (1998). Low dose scopolamine affects discriminability but not rate of forgetting in delayed conditional discrimination. Psychopharmacology, 96, 541-546.

Kopelman, M.D. & Corn, T.H. (1988). Cholinergic 'blockade' as a model for cholinergic depletion. Brain, 111, 1079-1110.
Liljequist, R. & Mattila M.J. (1979). Effect of physostigmine and scopolamine on the memory function of chess players. Medical Biology, 57, 402-5.

Martínez, A.M. & Mejia, M.X. (2001). Aspectos neuropsicológicos de la exposición a neurotóxicos. Neurotoxicología. Bogotá: Exlibris.

Martínez, R., Molchan, S.E., Lawlar, B.A., Thompson, K., Martinson, H., Latham, G., Weingartner, H. & Sundrland, T. (1997). Minimal effects of dextroanphetamine of scopolamine induced cognitive impairments in human. Biological Psychiatry, 41, 50-57.

Motta, G. (1982). Burundanga-Aspectos psiquiátricos repercusión social. Revista Colombiana de Psiquiatría, 11, 489-493.

Parrott, A.C. & Jones, R. (1985). Effects of transdermal scopolamine upon psychologycal test performance at sea. European Journal of clinical Pharmachology, 28, 419-23.

Rey Osterrieth, A. (1997), Test de copia y de reproducción de memoria de figuras geométricas complejas. (6ª ed.) Madrid: TEA.

Rusted, J.M. & Warburton D.M. (1998). The effects of scopolamine on working memory in healthy young volunteers. Psychopharmachology, 96, 145-52.

Sandstrom, N.J., Arnold, M. & Williams, Ch. (1998). Reactivation treatment prevents the memory-impaling effects of scopolamine in preweanling rats. Behavioral Neuroscience, 112, 909-919.

Sherman, S.J., Atri, A, Hasselmo, M.E., Stern, E. & Howard, M.
(2005). Scopolamine impairs human recognition memory: data and modeling. Behavioral Neurosciencie, 117,526-539.

Soban, D., Ruprecht, J., Keys, T.E. & Schneck, H.J. (1989). The history of scopolamine with special reference to its use in anesthesia. Anaesthesiologic and Reanimation, 14, 43-54.

Sugimoto, H., Yamanishi, Y., Limura, Y. & Kawakami, Y. (2000). Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors. Current Medicinal Chemistry, 7(3), 303-339.

Taffe, M.A., Weed, M.R. & Gold, L.H. (1999). Scopolamine alters rhesus monkey performance on a novel neuropsichological test battery. Cognitive Brain Research, 8, 203-212.

Tayebati, S.K., Amenta, F., Amicis, S., El-Assavad, D., Gallai, V., Ricci, A. & Parnetti, L. (2001). Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzhaimer's disease: a marker of cholinergic dysfunction?. Journal of Neuroimmunology, 121, 126-31.

Uribe, M. & Uribe, C. (2001) Neurotoxicidad por escopolamina y "nueva burundanga". Neurotoxicologia. Bogotá: Exilibris.
Wechsler, D. (1986). Wechsler Memory Scale. New York: The
Psychological Corporation.

Wechsler, D. (1997) Wechsler Memory Scale. San Antonio Texas: The Psychological Corporation

Ye, J.W., CaiJ. X., Wang, L.M. & Tang, X.C. (1999). Improving effects of Huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment. The Journal of Pharmachology and Experimental Therapeutics, 288, 814-819.
Cómo citar
Camelo Roa, S. M., & Ardila, A. (2013). Efectos de la escopolamina a corto y largo plazo en la memoria y las habilidades conceptuales. Diversitas, 9(2), 335-346. https://doi.org/10.15332/s1794-9998.2013.0002.07
Sección
Artículos